休克指数预测ST段抬高型心肌梗死患者预后的Meta分析

杨靓淇; 闵珺; 刘丽赟; 涂颉洪; 陈晖; 李顺辉

doi:10.13201/j.issn.1001-1439.2019.05.005

休克指数预测ST段抬高型心肌梗死患者预后的Meta分析

- 1. 南昌大学第三附属医院南昌市第一医院心内一科(南昌, 330006);
- 2. 南昌大学第三附属医院南昌市第一医院病案室
基金项目:
江西省卫生计生委科技计划（No：20187017）

详细信息

通讯作者: 陈晖,E-mail:2716554845@qq.com

中图分类号: R541.4

收稿日期: 2018-09-25

The value of shock index in evaluating the prognosis of patients with acute ST-segment elevation myocardial infarction: a Meta analysis

- 1. Department of Cardiology;
- 2. Record Room, The Third Affiliated Hospital of Nanchang University, The First Hospital of Nanchang, Nanchang, 330006, China

More Information

Corresponding author: CHEN Hui, E-mail: 2716554845@qq.com

Received Date: 25 September 2018

摘要

摘要: 目的：评估休克指数（shock index，SI）在急性ST段抬高型心肌梗死（acute ST-segment elevation myocardial infarction，STEMI）患者预后中的预测价值。方法：通过计算机检索Pubmed数据库、EMBASE数据库、Cochrane图书馆、中国生物医学文献数据库、CNKI数据库、万方中文科技期刊数据库（自建库起至2018年8月），搜集有关SI预测STEMI患者预后的相关文章，评估SI与STMEI患者预后的关系。结果：纳入9篇文献，包括STEMI患者22 607例，其中高SI患者6 258例（高SI组），正常SI患者16 349例（正常SI组）。Meta分析结果显示：正常SI组短期内发生主要心脏不良事件（major adverse cardiac events，MACE）（RR：0.48，95%CI：0.44~0.53，P<0.01）、死亡（RR：0.27，95%CI：0.23~0.31，P<0.01）、心源性休克（RR：0.20，95%CI：0.10~0.41，P<0.01）、致命性心律失常（RR：0.49，95%CI：0.42~0.57，P<0.01）的风险均显著低于高SI组；正常SI组30 d内出现死亡的风险显著低于高SI组（RR：0.40，95%CI：0.26~0.62，P<0.01）；正常SI组1年内发生MACE事件（RR：0.35，95%CI：0.23~0.54，P<0.01）、死亡（RR：0.27，95%CI：0.11~0.66，P<0.01）、心力衰竭（RR：0.26，95%CI：0.14~0.49，P<0.01）、心源性休克（RR：0.15，95%CI：0.12~0.18，P<0.01）的风险均显著低于高SI组；两组患者30 d及1年内再发心肌梗死差异无统计学意义。结论：SI能够有效预测STEMI患者短期、30 d及长期预后，可为临床提供一种简便易算的观察STEMI患者预后的指标。
- 休克指数 /
- ST段抬高型心肌梗死,急性 /
- 预后 /
- Meta分析
Abstract: Objective: To investigate the value of shock index (SI) in evaluating the prognosis of patients with acute ST-segment elevation myocardial infarction (STEMI).Method: The related data were obtained from Pubmed, EMBASE, Cochrane library, China Biomedical Literature Database, CNKI, Wanfang Chinese Science and Technology Journal Database (from the establishment of the library until August 2018), and collected the articles about SI in evaluating the prognosis of patients with STEMI, then assessed the relationship between SI and prognosis in patients with STEMI.Result: Nine studies including 22 607 patients with STEMI were included, 6 258 patients with high SI (high SI group) and 16 349 patients with normal SI (normal SI group).Meta-analysis showed that in the short-term, risks of major adverse cardiac events (MACEs) (RR:0.48, 95%CI:0.44-0.53, P<0.01), death (RR:0.27, 95%CI:0.23-0.31, P<0.01), cardiogenic shock (RR:0.20, 95%CI:0.10-0.41, P<0.01) and fatal arrhythmia (RR:0.49, 95%CI:0.42-0.57, P<0.01) in normal SI group were significant lower than those in high SI group.Within 30 days, the risk of death in normal SI group was significant lower than that in high SI group (RR:0.40, 95%CI:0.26-0.62, P<0.01).Within 1 year, risks of MACEs (RR:0.35, 95%CI:0.23-0.54, P<0.01), death (RR:0.27, 95%CI:0.11-0.66, P<0.01), heart failure (RR:0.26, 95%CI:0.14-0.49, P<0.01) and cardiogenic shock (RR:0.15, 95%CI:0.12-0.18, P<0.01) in normal SI group were lower than those in the high SI group, and the difference was statistically significant.There was no significant difference in recurrent myocardial infarction within 30 days or 1 year in two groups.Conclusion: SI can effectively predict the short-term, 30-day and long-term prognosis of patients with STEMI, and providing an easy-to-use indicator for evaluation of the prognosis of patients with STEMI.
- shock index /
- acute ST-segment elevation myocardial infarction /
- prognosis /
- Meta analysis

HTML全文

参考文献(19)

[1]	陈伟伟, 高润霖, 刘力生, 等.《中国心血管病报告2017》概要[J].中国循环杂志, 2018, 33(1):1-8.
[2]	Zhang X, Wang Z, Wang Z, et al.The prognostic value of shock index for the outcomes of acute myocardial infarction patients:A systematic review and meta-analysis[J].Medicine, 2017, 96(38):e8014.
[3]	Allgower M, Burri C.Shock index[J].Dtsch Med Wochenschr, 1967, 92(43):1947-1950.
[4]	Hwang JK, Jang WJ, Song YB, et al.Shock index as a predictor of myocardial injury in ST-segment elevation myocardial infarction[J].Am J Med Sci, 2016, 352(6):574-581.
[5]	Jadad AR, Moore RA, Carroll D, et al.Assessing the quality of reports of randomized clinical trials:is blinding necessary?[J].Control Clin Trials, 1996, 17(1):1-12.
[6]	Stang A.Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses[J].Eur J Epidemiol, 2010, 25(9):603-605.
[7]	Reinstadler SJ, Fuernau G, Eitel C, et al.Shock index as a predictor of myocardial damage and clinical outcome in ST-elevation myocardial infarction[J].Circ J, 2016, 80(4):924-930.
[8]	Bilkova D, Motovska Z, Widimsky P, et al.Shock index:a simple clinical parameter for quick mortality risk assessment in acute myocardial infarction[J].Can J Cardiol, 2011, 27(6):739-742.
[9]	Hemradj VV, Ottervanger JP, de Boer MJ, et al.Shock index more sensitive than cardiogenic shock in ST-elevation myocardial infarction treated by primary percutaneous coronary intervention[J].Circ J, 2017, 81(2):199-205.
[10]	Abe N, Miura T, Miyashita Y, et al.Long-term prognostic implications of the admission shock index in patients with acute myocardial infarction who received percutaneous coronary intervention[J].Angiology, 2017, 68(4), 339-345.
[11]	Huang B, Yang Y, Zhu J, et al.Usefulness of the admission shock index for predicting short-term outcomes in patients with ST-segment elevation myocardial infarction[J].Am J Cardiol, 2014, 114(9):1315-1321.
[12]	赵春生, 王艳飞, 孙海艳, 等.休克指数与修正休克指数在急诊对急性ST段抬高型心肌梗死短期预后判断中的预测价值[J].实用医学杂志, 2016, 32(24):4065-4069.
[13]	武佳科, 田春阳, 何东旭, 等.休克指数对行经皮冠状动脉介入治疗的急性心肌梗死患者长期预后的预测价值[J].中国医科大学学报, 2018, 47(6):522-526.
[14]	Spyridopoulos I, Noman A, Ahmed JM, et al.Shock-index as a novel predictor of long-term outcome following primary percutaneous coronary intervention[J].Eur Heart J Acute Cardiovasc Care, 2015, 4(3):270-277.
[15]	Shangguan Q, Xu JS, Su H, et al.Modified Shock Index is a Predictor for 7-Day Outcomes in Patients With STEMI[J].Am J Emerg Med, 2015, 33(8):1072-1075.
[16]	Yan AT, Yan RT, Tan M, et al.In-hospital revascularization and one-year outcome of acute coronary syndrome patients stratified by the GRACE risk score[J].Am J Cardiol, 2005, 96(7):913-916.
[17]	Morrow DA, Antman EM, Charlesworth A, et al.TIMI risk score for ST-elevation myocardial infarction:A convenient, bedside, clinical score for risk assessment at presentation:An intravenous nPA for treatment of infarcting myocardium early II trial substudy[J].Circulation, 2000, 102(17):2031-2037.
[18]	Abreu G, Azevedo P, Galvão CB, et al.Modified shock index:A bedside clinical index for risk assessment of ST-segment elevation myocardial infarction at presentation[J].Rev Port Cardiol, 2018, 37(6):481-488.
[19]	Yu T, Tian C, Song J, et al.Age shock index is superior to shock index and modified shock index for predicting long-term prognosis in acute myocardial infarction[J].Shock, 2017, 48(5):545-550.